top of page
Browse by category
Search


OMP reveals additional three-month data for its Sirona dual-polymer hydrogel pill
Oxford Medical Products (OMP) has announced the additional three-month clinical trial results for Sirona, a weight-loss treatment...


Oxford Medical Products’ Sirona inert dual-polymer hydrogel pill can result in 10% TBWL
Oxford Medical Products has announced positive topline results from the first randomised controlled trial (RCT) of Sirona, its...

OMP begins first human trial of self-expanding hydrogel capsule Sirona
Oxford Medical Products (OMP) has initiated the first human trial of Sirona, its self-expanding hydrogel capsule which aims to deliver a...

Oxford Medical Products gains £2.5 million funding for weight-loss hydrogel technology
Oxford Medical Products has raised £2.5M in equity investment to conduct the first human trials of Sirona, its weight-loss platform....

OMP receives €1.3 million for Sirona self-expanding hydrogel weight loss capsule
Oxford Medical Products (OMP) has raised €1.3 million to develop a safe and affordable weight loss capsule, which uses the same mechanism...
Browse by tag




bottom of page